Multi-modal cancer therapy using viral hitchhiking
Cancer therapies based on immunological methods are a rapidly expanding field of cancer treatment options. However, one major problem immunebased cancer therapies face is that cancer cells manage to escape immunological control during their evolution. Methods enabling the immune system to rerecognize tumor cells are therefore an essential part of immune cancer therapies. The present invention is based on a fusion protein that substantially enhances the tumordestroying effect of T-cells against tumor cells marked with Newcastle disease virus (NDV).
Further Information: PDF
DKFZ (German Cancer Research Center, Deutsches Krebsforschungszentrum)
Phone: +49-6221-42 2955
Contact
Dr. Ruth Herzog
Media Contact
All latest news from the category: Technology Offerings
Newest articles
High-energy-density aqueous battery based on halogen multi-electron transfer
Traditional non-aqueous lithium-ion batteries have a high energy density, but their safety is compromised due to the flammable organic electrolytes they utilize. Aqueous batteries use water as the solvent for…
First-ever combined heart pump and pig kidney transplant
…gives new hope to patient with terminal illness. Surgeons at NYU Langone Health performed the first-ever combined mechanical heart pump and gene-edited pig kidney transplant surgery in a 54-year-old woman…
Biophysics: Testing how well biomarkers work
LMU researchers have developed a method to determine how reliably target proteins can be labeled using super-resolution fluorescence microscopy. Modern microscopy techniques make it possible to examine the inner workings…
